Stockreport

Inventiva drops after adverse event in Phase 3 trial for NASH drug [Seeking Alpha]

Inventiva S.A. - American Depository Shares  (IVA) 
PDF NASH, also known as nonalcoholic steatohepatitis, is characterized by the excessive accumulation of liver fat. An advanced form of nonalcoholic fatty liver disease, NAS [Read more]